10270000: Erythromycin estolate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Antibacterial\Substance with macrolide structure and antibacterial mechanism of action (substance)\Erythromycin estolate

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Antibacterial\Substance with macrolide structure and antibacterial mechanism of action (substance)\Erythromycin estolate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Lactone (substance)\Macrolide (substance)\Substance with macrolide structure and antibacterial mechanism of action (substance)\Erythromycin estolate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

17893017 Erythromycin estolate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

17894011 Erythromycin propionate lauryl sulfate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

253584014 Erythromycin propionate lauryl sulphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

543831019 Erythromycin estolate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

809441000172112 érythromycine estolate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Erythromycin estolate	Is a	Product containing erythromycin (medicinal product)	false	Inferred relationship	Some
Erythromycin estolate	Is a	Erythromycin (substance)	false	Inferred relationship	Some
Erythromycin estolate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Erythromycin (substance)	true	Inferred relationship	Some
Erythromycin estolate	Is a	Substance with macrolide structure and antibacterial mechanism of action (substance)	true	Inferred relationship	Some
Erythromycin estolate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antibacterial (disposition)	true	Inferred relationship	Some
Erythromycin estolate	Is a	Macrolide (substance)	false	Inferred relationship	Some
Erythromycin estolate	Is a	Antibacterial	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Erythromycin estolate 250 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin estolate	Inferred relationship	Some
Erythromycin estolate 25 mg/mL oral suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin estolate	Inferred relationship	Some
Erythromycin estolate 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin estolate	Inferred relationship	Some
Product containing precisely erythromycin estolate 50 milligram/1 milliliter conventional release oral suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin estolate	Inferred relationship	Some
Erythromycin estolate 250 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin estolate	Inferred relationship	Some	1
Erythromycin estolate 250 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Erythromycin estolate	Inferred relationship	Some	1
Erythromycin estolate 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin estolate	Inferred relationship	Some	1
Erythromycin estolate 500 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Erythromycin estolate	Inferred relationship	Some	1
Erythromycin estolate 500 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Erythromycin estolate	Inferred relationship	Some	1
Erythromycin estolate 250 mg oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Erythromycin estolate	Inferred relationship	Some	1
Erythromycin estolate 25 mg/mL oral suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Erythromycin estolate	Inferred relationship	Some	1
Erythromycin estolate 25 mg/mL oral suspension	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Erythromycin estolate	Inferred relationship	Some	1
Product containing precisely erythromycin estolate 50 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Erythromycin estolate	Inferred relationship	Some	1
Product containing precisely erythromycin estolate 50 milligram/1 milliliter conventional release oral suspension (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Erythromycin estolate	Inferred relationship	Some	1

Reference Sets